Psychiatry and Neurology, Neurology · Burlington, VT
NPI
1417970559
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
111 Colchester Ave, Patrick 5
Burlington, VT, 05401
Phone (802) 847-2788
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
490 services
Medicare patients, 2024
344
Average age 64
Drug cost, 2024
$701K
3,503 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keith Nagle was code 99213 (office e&m - established), 127 times for 109 patients. In total Keith Nagle billed 490 services in 20 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 127 | 109 | $34.82 | $4,422 |
| 95720 Neurologic | Facility | 126 | 69 | $150.14 | $19K |
| 99213 Office E&M - Established | Office | 88 | 85 | $51.76 | $4,555 |
| 95718 Neurologic | Facility | 42 | 41 | $98.21 | $4,125 |
| 99214 Office E&M - Established | Facility | 21 | 21 | $51.85 | $1,089 |
| 95816 Neurologic | Facility | 20 | 20 | $40.68 | $814 |
| 99204 Office E&M - New | Office | 12 | 12 | $103.08 | $1,237 |
| 99214 Office E&M - Established | Office | 12 | 12 | $83.61 | $1,003 |
By year: 2022 $45K for 595 services; 2023 $44K for 534 services; 2024 $40K for 490 services.
Medicare prescription drug claims, 2024
In 2024, the drug Keith Nagle prescribed most often to Medicare patients was Lamotrigine, with 568 prescriptions and refills. In total Keith Nagle wrote 3,503 Medicare prescriptions that cost $701K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 568 | 858 | 72 | $12K |
| Levetiracetam Generic | 541 | 875 | 87 | $30K |
| Topiramate Generic | 276 | 370 | 26 | $3,892 |
| Lacosamide Generic | 263 | 303 | 28 | $34K |
| Zonisamide Generic | 260 | 398 | 42 | $8,228 |
| Divalproex Sodium Er Divalproex Sodium | 194 | 259 | 25 | $12K |
| Clobazam Generic | 137 | 160 | 18 | $18K |
| Lamotrigine Er Lamotrigine | 112 | 159 | 14 | $30K |
| Xcopri Cenobamate | 103 | 111 | 11 | $151K |
| Oxcarbazepine Generic | 90 | 133 | 12 | $6,911 |
| Fycompa Perampanel | 79 | 93 | Under 11 | $108K |
| Divalproex Sodium Generic | 71 | 115 | 13 | $9,304 |
| Levetiracetam Er Levetiracetam | 68 | 84 | Under 11 | $4,206 |
| Carbamazepine Er Carbamazepine | 62 | 94 | Under 11 | $6,680 |
| Felbamate Generic | 60 | 76 | Under 11 | $25K |
Brand drugs: 394 claims; generic drugs: 3,068 claims; opioid claims: 12.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Keith Nagle were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.